Description
IPH-2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, monolizumab,anti-NKG2A, humZ270, CAS: 1228763-95-8
Targets
KLRC1, NKG2-A/NKG2-B type II integral membrane protein, NKG2-A/B-activating NK receptor, CD159 antigen-like family member A, CD159a, NK cell receptor A, NKG2A
Isotype/Mimetic
IgG4-kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression